Viruses (Apr 2021)

Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country

  • Jiwon Jung,
  • Jinyeong Kim,
  • Joon Seo Lim,
  • Eun Ok Kim,
  • Mi-Na Kim,
  • Sung-Han Kim

DOI
https://doi.org/10.3390/v13050804
Journal volume & issue
Vol. 13, no. 5
p. 804

Abstract

Read online

It is unclear whether universal PCR screening for SARS-CoV-2 in asymptomatic individuals prior to admission is useful. From April to December 2020, the positive rate of universal pre-admission screening was 0.005% (4/76,521) in a tertiary care hospital in Korea. The positive rates were not different between the periods (period 1 (daily new patients of P = 0.45). Universal pre-admission screening for SARS-CoV-2 had a lower positive rate than that of symptom-based screening (0.005% vs. 0.049% (53/109,257), p < 0.001). In addition, seven patients with negative pre-admission test results had subsequent positive PCR during hospitalization, and four patients had secondary transmission. Universal pre-admission PCR screening may not be practical in settings of low prevalence of COVID-19, and negative PCR results at admission should not serve as a basis for underestimating the risk of nosocomial spread from asymptomatic patients.

Keywords